← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 17, 2017Last known activity
Nov 30, 2025
Timeline
2010s
- Jun 1, 2012
Wave Life Sciences— Founded
Drugs by trial phase (8 distinct, 14 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (28)
- NCT07209332Lead sponsorPhase 2Nov 30, 2025
- NCT07209332OfficialPhase 2Nov 30, 2025
- NCT06842186OfficialPhase 1Jan 31, 2025
- NCT06842186Lead sponsorPhase 1Jan 31, 2025
- NCT06405633Lead sponsorPhase 1/Phase 2Jul 19, 2024
- NCT06405633OfficialPhase 1/Phase 2Jul 19, 2024
- NCT06186492OfficialPhase 1Nov 14, 2023
- NCT06186492Lead sponsorPhase 1Nov 14, 2023
- NCT05683860Lead sponsorPhase 1/Phase 2Dec 14, 2022
- NCT05683860Study directorPhase 1/Phase 2Dec 14, 2022
- NCT04906460Lead sponsorPhase 1/Phase 2Sep 28, 2021
- NCT04906460Study directorPhase 1/Phase 2Sep 28, 2021
- NCT05032196Study directorPhase 1/Phase 2Sep 6, 2021
- NCT05032196Lead sponsorPhase 1/Phase 2Sep 6, 2021
- NCT04931862Lead sponsorPhase 1/Phase 2Jun 28, 2021
Details
- Founded
- Boston, MA, US Jun 1, 2012
- Last known activity
- Nov 30, 2025